Oct. 10 (Bloomberg) -- Pharmaceutical Product Development Inc. plans to finance its buyout by Carlyle Group and Hellman & Friedman LLC with $2.2 billion of debt, according to a person with knowledge of the matter.
The company is seeking a $1.325 billion first-lien term loan, a $175 million revolving credit line and $700 million of bridge financing, said the person, who declined to be identified because the deal is private.
Carlyle and Hellman & Friedman have agreed to buy Pharmaceutical Product Development in a deal valued at $3.9 billion.
To contact the reporter on this story: Christine Idzelis in New York at firstname.lastname@example.org
To contact the editor responsible for this story: Faris Khan at email@example.com